PVI
VRTX icon

Pura Vida Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Pura Vida Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-97,000
Closed -$21.3M – 285
2021
Q4 		$21.3M Sell
97,000
-3,000
-3% -$583K 0.77% 32
2021
Q3 		$18.1M Buy
+100,000
New +$19.5M 0.55% 42

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pura Vida Investments's VRTX Position: Q1 2023 in Review

Pura Vida Investments sold out of Vertex Pharmaceuticals (VRTX) in Q1 2023, closing a stake of 2,800 shares — an estimated $809K sold.

Pura Vida Investments first reported a position in VRTX in Q3 2017 and held it in 9 quarters. The position peaked at $21.9M in Q1 2022. 1,208 funds tracked by Wall St. Rank hold VRTX as of Q1 2023.

  • Pura Vida Investments reported no remaining Vertex Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Pura Vida Investments sold 2,800 Vertex Pharmaceuticals shares in Q1 2023, an estimated $809K.
  • Pura Vida Investments first reported a position in Vertex Pharmaceuticals in Q3 2017 and held it in 9 quarters.
  • Pura Vida Investments's Vertex Pharmaceuticals position peaked at $21.9M in Q1 2022.
  • 1,208 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.